Alemtuzumab or Tocilizumab in Combination With Etoposide and Dexamethasone for the Treatment of Adult Patients With Hemophagocytic Lymphohistiocytosis
Phase of Trial: Phase II
Latest Information Update: 06 Mar 2018
At a glance
- Drugs Alemtuzumab (Primary) ; Alemtuzumab (Primary) ; Dexamethasone (Primary) ; Etoposide (Primary) ; Methotrexate (Primary) ; Tocilizumab (Primary)
- Indications Haemophagocytic lymphohistiocytosis
- Focus Adverse reactions; Therapeutic Use
- 01 Mar 2018 Planned End Date changed from 1 Sep 2019 to 1 Sep 2020.
- 03 Jan 2018 Planned End Date changed from 1 Sep 2018 to 1 Sep 2019.
- 03 Jan 2018 Planned primary completion date changed from 1 Sep 2018 to 1 Sep 2019.